Needham Maintains Buy on iRhythm Holdings, Raises Price Target to $194

10/5/2026
Impact: 70
Healthcare

Needham analyst David Saxon has maintained a Buy rating on iRhythm Holdings (NASDAQ: IRTC) and increased the price target from $192 to $194. This adjustment reflects the analyst's positive outlook on the company's performance.

AI summary, not financial advice

Share: